Moderna Upgraded by Argus to Buy, Friday's Top Analyst Moves

Wall Street's top analysts adjusted their ratings on the following key stocks. For the full list of analyst rating changes, visit our analyst ratings page.

Argus Research analyst John Eade upgraded Moderna Inc from Hold to Buy with a $180 price target. Moderna closed Thursday at $142.77. See how other analysts rate the stock.

Northland Capital Markets analyst Jeff Grampp upgraded Evolution Petroleum Corporation from Market Perform to Outperform with a $4 price target. Evolution Petroleum closed Thursday at $3.58. See how other analysts rate the stock.

CIBC analyst Robert Catellier upgraded Enbridge from Neutral to Outperform and raised the price target from C$77 to C$78. See how other analysts rate the stock.

Considering buying MRNA stock? Here's what analysts say.